Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Based on evidence that the local anesthetic lidocaine may have anticancer effects, this study will assess the safety and efficacy of intratumoral lidocaine injection at the time of direct laryngoscopy prior to TransOral Robotic Surgery (TORS) and neck dissection for oropharyngeal squamous cell carcinoma (OPSCC). The primary objective of the study is to determine if intratumoral lidocaine injection is safe and causes a major pathologic treatment effect in the primary tumor following surgical resection. The secondary objectives will be to determine if intratumoral lidocaine injection improves lo

Trial Details

NCT ID
NCT06747390
Phase
PHASE1
Sponsor
Ryan Carey
Status
RECRUITING
Cancer Type
Squamous Cell Head and Neck Cancer
Interventions
  • Lidocaine 1% Injectable Solution
Locations (sample)
  • Philadelphia, Pennsylvania, United States|39.95238,-75.16362

Key Eligibility Criteria

  • Patients 18 years older or more.
  • Histologically confirmed diagnosis of squamous cell carcinoma of the oropharynx or neck.
  • Clinical T1, T2, T3, or T4 stage disease of the oropharynx (per AJCC 8th Ed).
  • Any clinical N stage disease (per AJCC 8th Ed).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Squamous Cell Head and Neck Cancer Trials on Trialify →